GRISEOFULVIN, MICROCRYSTALLINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for griseofulvin, microcrystalline and what is the scope of patent protection?
Griseofulvin, microcrystalline
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst, Johnson And Johnson, J And J, and Valeant Luxembourg, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Summary for GRISEOFULVIN, MICROCRYSTALLINE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 7,529 |
DailyMed Link: | GRISEOFULVIN, MICROCRYSTALLINE at DailyMed |
US Patents and Regulatory Information for GRISEOFULVIN, MICROCRYSTALLINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Luxembourg | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 062279-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | GRISACTIN | griseofulvin, microcrystalline | CAPSULE;ORAL | 050051-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Luxembourg | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 062279-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |